BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: de Gaetano Donati K, Rabagliati R, Tumbarello M, Tacconelli E, Amore C, Cauda R, Lacoviello L. Increased soluble markers of endothelial dysfunction in HIV-positive patients under highly active antiretroviral therapy. AIDS 2003;17:765-8. [PMID: 12646805 DOI: 10.1097/00002030-200303280-00020] [Cited by in Crossref: 42] [Cited by in F6Publishing: 40] [Article Influence: 2.2] [Reference Citation Analysis]
Number Citing Articles
1 Huson MA, Kalkman R, Hoogendijk AJ, Alabi AS, van 't Veer C, Grobusch MP, Meijers JC, van der Poll T. Impact of HIV infection on the haemostatic response during sepsis and malaria. Br J Haematol 2016;173:918-26. [PMID: 26970408 DOI: 10.1111/bjh.14006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
2 Melendez MM, Mcnurlan MA, Mynarcik DC, Khan S, Gelato MC. Endothelial Adhesion Molecules Are Associated with Inflammation in Subjects with HIV Disease. Clinical Infectious Diseases 2008;46:775-80. [DOI: 10.1086/527563] [Cited by in Crossref: 31] [Cited by in F6Publishing: 29] [Article Influence: 2.2] [Reference Citation Analysis]
3 de Gaetano Donati K, Cauda R, Iacoviello L. HIV Infection, Antiretroviral Therapy and Cardiovascular Risk. Mediterr J Hematol Infect Dis 2010;2:e2010034. [PMID: 21776340 DOI: 10.4084/MJHID.2010.034] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.8] [Reference Citation Analysis]
4 Gresele P, Falcinelli E, Sebastiano M, Baldelli F. Endothelial and platelet function alterations in HIV-infected patients. Thrombosis Research 2012;129:301-8. [DOI: 10.1016/j.thromres.2011.11.022] [Cited by in Crossref: 53] [Cited by in F6Publishing: 53] [Article Influence: 5.3] [Reference Citation Analysis]
5 De Luca A, de Gaetano Donati K, Colafigli M, Cozzi-Lepri A, De Curtis A, Gori A, Sighinolfi L, Giacometti A, Capobianchi MR, D'Avino A, Iacoviello L, Cauda R, D'Arminio Monforte A. The association of high-sensitivity c-reactive protein and other biomarkers with cardiovascular disease in patients treated for HIV: a nested case-control study. BMC Infect Dis 2013;13:414. [PMID: 24004495 DOI: 10.1186/1471-2334-13-414] [Cited by in Crossref: 33] [Cited by in F6Publishing: 33] [Article Influence: 3.7] [Reference Citation Analysis]
6 Rana MA, Beedupalli J, Akkus NI. Unusual Response of Subclavian In-Stent Restenosis to Balloon Angioplasty in a Patient with HIV. Case Rep Vasc Med 2015;2015:157623. [PMID: 25685591 DOI: 10.1155/2015/157623] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Calza L, Manfredi R, Pocaterra D, Chiodo F. Risk of premature atherosclerosis and ischemic heart disease associated with HIV infection and antiretroviral therapy. Journal of Infection 2008;57:16-32. [DOI: 10.1016/j.jinf.2008.02.006] [Cited by in Crossref: 47] [Cited by in F6Publishing: 39] [Article Influence: 3.4] [Reference Citation Analysis]
8 Younas M, Psomas C, Reynes J, Corbeau P. Immune activation in the course of HIV-1 infection: Causes, phenotypes and persistence under therapy. HIV Med. 2016;17:89-105. [PMID: 26452565 DOI: 10.1111/hiv.12310] [Cited by in Crossref: 82] [Cited by in F6Publishing: 86] [Article Influence: 11.7] [Reference Citation Analysis]
9 Wirunsawanya K, Belyea L, Shikuma C, Watanabe RM, Kohorn L, Shiramizu B, Mitchell BI, Souza SA, Keating SM, Norris PJ, Ndhlovu LC, Chow D. Plasminogen Activator Inhibitor-1 Predicts Negative Alterations in Whole-Body Insulin Sensitivity in Chronic HIV Infection. AIDS Res Hum Retroviruses 2017;33:723-7. [PMID: 28322572 DOI: 10.1089/AID.2016.0292] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
10 Skowyra A, Zdziechowicz I, Mikuła T, Wiercińska-drapało A. Endothelial dysfunction—An important factor in the progression of atherosclerosis in HIV-infected persons. HIV & AIDS Review 2012;11:57-60. [DOI: 10.1016/j.hivar.2012.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Francisci D, Giannini S, Baldelli F, Leone M, Belfiori B, Guglielmini G, Malincarne L, Gresele P. HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction. AIDS 2009;23:589-96. [PMID: 19177019 DOI: 10.1097/QAD.0b013e328325a87c] [Cited by in Crossref: 98] [Cited by in F6Publishing: 48] [Article Influence: 7.5] [Reference Citation Analysis]
12 de Gaetano Donati K, Rabagliati R, Iacoviello L, Cauda R. HIV infection, HAART, and endothelial adhesion molecules: current perspectives. Lancet Infect Dis 2004;4:213-22. [PMID: 15050939 DOI: 10.1016/S1473-3099(04)00971-5] [Cited by in Crossref: 99] [Cited by in F6Publishing: 41] [Article Influence: 5.5] [Reference Citation Analysis]
13 Vishwanath A, Quaiser S, Khan R. Role of high-sensitivity C-reactive protein measurements in HIV patients. Indian J Sex Transm Dis AIDS 2016;37:123-8. [PMID: 27890944 DOI: 10.4103/0253-7184.192127] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
14 Tumbarello M, Rabagliati R, de Gaetano Donati K, Bertagnolio S, Montuori E, Tamburrini E, Tacconelli E, Cauda R. Older age does not influence CD4 cell recovery in HIV-1 infected patients receiving highly active antiretroviral therapy. BMC Infect Dis 2004;4:46. [PMID: 15530169 DOI: 10.1186/1471-2334-4-46] [Cited by in Crossref: 52] [Cited by in F6Publishing: 51] [Article Influence: 2.9] [Reference Citation Analysis]
15 Hsue PY, Waters DD. What a Cardiologist Needs to Know About Patients With Human Immunodeficiency Virus Infection. Circulation 2005;112:3947-57. [DOI: 10.1161/circulationaha.105.546465] [Cited by in Crossref: 33] [Cited by in F6Publishing: 10] [Article Influence: 1.9] [Reference Citation Analysis]
16 Kappert K, Leppänen O, Paulsson J, Furuhashi M, Carlsson M, Heldin C, Fätkenheuer G, Rosenkranz S, Östman A. Highly Active Antiretroviral Therapy Attenuates Re-Endothelialization and Alters Neointima Formation in the Rat Carotid Artery After Balloon Injury. JAIDS Journal of Acquired Immune Deficiency Syndromes 2006;43:383-92. [DOI: 10.1097/01.qai.0000232610.93867.2f] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.6] [Reference Citation Analysis]
17 Maisa A, Westhorpe C, Elliott J, Jaworowski A, Hearps AC, Dart AM, Hoy J, Crowe SM. Premature onset of cardiovascular disease in HIV-infected individuals: the drugs and the virus. HIV Therapy 2010;4:675-92. [DOI: 10.2217/hiv.10.53] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
18 Calza L, Verucchi G, Pocaterra D, Pavoni M, Alfieri A, Cicognani A, Manfredi R, Serra C, Chiodo F. Cardiovascular risk factors and ultrasound evaluation of carotid atherosclerosis in patients with HIV-1 infection. Int J STD AIDS 2009;20:683-9. [DOI: 10.1258/ijsa.2009.008504] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
19 Jiang B, Khandelwal AR, Rogers LK, Hebert VY, Kleinedler JJ, Zavecz JH, Shi W, Orr AW, Dugas TR. Antiretrovirals induce endothelial dysfunction via an oxidant-dependent pathway and promote neointimal hyperplasia. Toxicol Sci 2010;117:524-36. [PMID: 20621964 DOI: 10.1093/toxsci/kfq213] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 2.0] [Reference Citation Analysis]
20 Alkhalil M, Conlon CP, Ashrafian H, Choudhury RP. Aggressive restenosis after percutaneous intervention in two coronary loci in a patient with human immunodeficiency virus infection. World J Clin Cases 2017; 5(2): 40-45 [PMID: 28255546 DOI: 10.12998/wjcc.v5.i2.40] [Reference Citation Analysis]
21 Baekken M, Os I, Sandvik L, Oektedalen O. Hypertension in an urban HIV-positive population compared with the general population: influence of combination antiretroviral therapy. Journal of Hypertension 2008;26:2126-33. [DOI: 10.1097/hjh.0b013e32830ef5fb] [Cited by in Crossref: 76] [Cited by in F6Publishing: 38] [Article Influence: 5.4] [Reference Citation Analysis]
22 Jiang B, Hebert VY, Zavecz JH, Dugas TR. Antiretrovirals induce direct endothelial dysfunction in vivo. J Acquir Immune Defic Syndr 2006;42:391-5. [PMID: 16810107 DOI: 10.1097/01.qai.0000228790.40235.0c] [Cited by in Crossref: 36] [Cited by in F6Publishing: 38] [Article Influence: 2.3] [Reference Citation Analysis]
23 Granja MF, Monteiro A, Day J, Hanel R. HIV vasculopathy versus VZV vasculitis in an HIV patient with multiple brain ischaemic infarcts. BMJ Case Rep 2019;12:e229412. [PMID: 31315843 DOI: 10.1136/bcr-2019-229412] [Reference Citation Analysis]
24 Nkeh-Chungag BN, Goswami N, Engwa GA, Sewani-Rusike CR, Mbombela V, Webster I, De Boever P, Kessler HH, Stelzl E, Strijdom H. Relationship between Endothelial Function, Antiretroviral Treatment and Cardiovascular Risk Factors in HIV Patients of African Descent in South Africa: A Cross-Sectional Study. J Clin Med 2021;10:392. [PMID: 33498530 DOI: 10.3390/jcm10030392] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Sipsas NV, Sfikakis PP. Expanding role of circulating adhesion molecules in assessing prognosis and treatment response in human immunodeficiency virus infection. Clin Diagn Lab Immunol 2004;11:996-1001. [PMID: 15539496 DOI: 10.1128/CDLI.11.6.996-1001.2004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
26 Nehal M, Muredach R. Atherosclerotic Cardiovascular Disease Risk in the HAART-Treated HIV-1 Population. HIV Clinical Trials 2015;6:5-24. [DOI: 10.1310/ht0w-nx2n-u2bm-7luu] [Cited by in Crossref: 21] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Calza L, Pocaterra D, Pavoni M, Colangeli V, Manfredi R, Verucchi G, Chiodo F, Cantu M, Pariali M. Plasma Levels of VCAM-1, ICAM-1, E-Selectin, and P-Selectin in 99 HIV-Positive Patients Versus 51 HIV-Negative Healthy Controls. JAIDS Journal of Acquired Immune Deficiency Syndromes 2009;50:430-2. [DOI: 10.1097/qai.0b013e31819a292c] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 2.0] [Reference Citation Analysis]
28 Huson MA, Grobusch MP, van der Poll T. The effect of HIV infection on the host response to bacterial sepsis. Lancet Infect Dis 2015;15:95-108. [PMID: 25459220 DOI: 10.1016/S1473-3099(14)70917-X] [Cited by in Crossref: 19] [Cited by in F6Publishing: 12] [Article Influence: 2.4] [Reference Citation Analysis]
29 Syed SS, Balluz RS, Kabagambe EK, Meyer WA 3rd, Lukas S, Wilson CM, Kapogiannis BG, Nachman SA, Sleasman JW. Assessment of biomarkers of cardiovascular risk among HIV type 1-infected adolescents: role of soluble vascular cell adhesion molecule as an early indicator of endothelial inflammation. AIDS Res Hum Retroviruses 2013;29:493-500. [PMID: 23062187 DOI: 10.1089/AID.2012.0086] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
30 Su T, Mutsaerts HJ, Caan MW, Wit FW, Schouten J, Geurtsen GJ, Sharp DJ, Prins M, Richard E, Portegies P, Reiss P, Majoie CB; AGEhIV Cohort Study. Cerebral blood flow and cognitive function in HIV-infected men with sustained suppressed viremia on combination antiretroviral therapy. AIDS 2017;31:847-56. [PMID: 28121708 DOI: 10.1097/QAD.0000000000001414] [Cited by in Crossref: 23] [Cited by in F6Publishing: 13] [Article Influence: 4.6] [Reference Citation Analysis]
31 Chastain DB, King TS, Stover KR. Infectious and Non-infectious Etiologies of Cardiovascular Disease in Human Immunodeficiency Virus Infection. Open AIDS J 2016;10:113-26. [PMID: 27583063 DOI: 10.2174/1874613601610010113] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
32 Calza L, Manfredi R, Verucchi G. Myocardial infarction risk in HIV-infected patients: epidemiology, pathogenesis, and clinical management. AIDS 2010;24:789-802. [PMID: 20224307 DOI: 10.1097/QAD.0b013e328337afdf] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
33 Arildsen H, Sørensen K, Ingerslev J, Østergaard L, Laursen A. Endothelial dysfunction, increased inflammation, and activated coagulation in HIV-infected patients improve after initiation of highly active antiretroviral therapy: Endothelial dysfunction in HIV-infected patients. HIV Med 2013;14:1-9. [DOI: 10.1111/j.1468-1293.2012.01027.x] [Cited by in Crossref: 42] [Cited by in F6Publishing: 41] [Article Influence: 4.2] [Reference Citation Analysis]
34 Benjamin LA, Bryer A, Emsley HC, Khoo S, Solomon T, Connor MD. HIV infection and stroke: current perspectives and future directions. Lancet Neurol 2012;11:878-90. [PMID: 22995692 DOI: 10.1016/S1474-4422(12)70205-3] [Cited by in Crossref: 150] [Cited by in F6Publishing: 76] [Article Influence: 15.0] [Reference Citation Analysis]
35 Grome HN, Barnett L, Hagar CC, Harrison DG, Kalams SA, Koethe JR. Association of T Cell and Macrophage Activation with Arterial Vascular Health in HIV. AIDS Res Hum Retroviruses 2017;33:181-6. [PMID: 27527002 DOI: 10.1089/AID.2016.0113] [Cited by in Crossref: 27] [Cited by in F6Publishing: 24] [Article Influence: 5.4] [Reference Citation Analysis]
36 Kristoffersen US, Kofoed K, Kronborg G, Giger AK, Kjaer A, Lebech AM. Reduction in circulating markers of endothelial dysfunction in HIV-infected patients during antiretroviral therapy. HIV Med 2009;10:79-87. [PMID: 19200170 DOI: 10.1111/j.1468-1293.2008.00661.x] [Cited by in Crossref: 37] [Cited by in F6Publishing: 41] [Article Influence: 2.8] [Reference Citation Analysis]
37 Temu TM, Polyak SJ, Zifodya JS, Wanjalla CN, Koethe JR, Masyuko S, Nyabiage J, Kinuthia J, Gervassi AL, Oyugi J, Page S, Farquhar C. Endothelial Dysfunction Is Related to Monocyte Activation in Antiretroviral-Treated People With HIV and HIV-Negative Adults in Kenya. Open Forum Infect Dis 2020;7:ofaa425. [PMID: 33094120 DOI: 10.1093/ofid/ofaa425] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
38 Miller TL, Somarriba G, Orav EJ, Mendez AJ, Neri D, Schaefer N, Forster L, Goldberg R, Scott GB, Lipshultz SE. Biomarkers of vascular dysfunction in children infected with human immunodeficiency virus-1. J Acquir Immune Defic Syndr 2010;55:182-8. [PMID: 20531209 DOI: 10.1097/QAI.0b013e3181e222c9] [Cited by in Crossref: 29] [Cited by in F6Publishing: 19] [Article Influence: 2.4] [Reference Citation Analysis]
39 Mata-Marín JA, Méndez-Cruz R, Arroyo-Anduiza CI, Mata-Marín LA, Gaytán-Martínez J, Asbún-Bojalil J. Effect of antiretroviral therapy on inflammatory markers of endothelial dysfunction in HIV treatment-naïve infected patients. J Med Virol 2013;85:1321-6. [PMID: 23765771 DOI: 10.1002/jmv.23624] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.7] [Reference Citation Analysis]
40 Calza DL, Manfredi R, Chiodo F. Cardiovascular risk associated with antiretroviral therapy in HIV-infected patients. Expert Opinion on Therapeutic Patents 2006;16:1497-516. [DOI: 10.1517/13543776.16.11.1497] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]